CareDx

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CareDx and other ETFs, options, and stocks.

About CDNA

CareDx, Inc. operates as a transplant diagnostics company, which discovers, develops and commercializes diagnostic solutions. Its products include AlloMap, AlloSure and Laboratory products. 

CEO
John W. Hanna
CEOJohn W. Hanna
Employees
765
Employees765
Headquarters
Brisbane, California
HeadquartersBrisbane, California
Founded
1998
Founded1998
Employees
765
Employees765

CDNA Key Statistics

Market cap
1.47B
Market cap1.47B
Price-Earnings ratio
-185.01
Price-Earnings ratio-185.01
Dividend yield
Dividend yield
Average volume
872.83K
Average volume872.83K
High today
$29.32
High today$29.32
Low today
$28.11
Low today$28.11
Open price
$29.05
Open price$29.05
Volume
665.78K
Volume665.78K
52 Week high
$30.00
52 Week high$30.00
52 Week low
$10.96
52 Week low$10.96

Stock Snapshot

The current CareDx(CDNA) stock price is $29.01, with a market capitalization of 1.47B. The stock trades at a price-to-earnings (P/E) ratio of -185.01.

On 2026-07-11, CareDx(CDNA) stock moved within a range of $28.11 to $29.32. With shares now at $29.01, the stock is trading +3.2% above its intraday low and -1.1% below the session's peak.

Trading activity shows a volume of 665.78K, compared to an average daily volume of 872.83K.

The stock's 52-week range extends from a low of $10.96 to a high of $30.00.

The stock's 52-week range extends from a low of $10.96 to a high of $30.00.

CDNA News

TipRanks 3d
CareDx Refocuses Portfolio With Naveris Oncology Acquisition

Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions. Discover top stock picks and new invest...

Nasdaq 4d
CareDx Completes Naveris Acquisition and Expands Oncology Reach

CareDx CDNA recently completed the acquisition of Naveris, expanding its presence in high-growth specialty oncology. The company had announced the acquisition a...

CareDx Completes Naveris Acquisition and Expands Oncology Reach

Analyst ratings

57%

of 7 ratings
Buy
42.9%
Hold
57.1%
Sell
0%

People also own

Based on the portfolios of people who own CDNA. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.